CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 248 entries

View as:

Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients

Phase: N/A Priority: Normal

NCT ID: NCT00818623 Org: User:

Start: 11/30/02 End: 10/31/04 Due: 10/31/05

To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice

Phase: N/A Priority: Normal

NCT ID: NCT07029451 Org: User:

Start: 07/31/25 End: 09/30/28 Due: 09/30/29

MENOPUR® Versus FOLLISTIM®

Phase: N/A Priority: Normal

NCT ID: NCT00802360 Org: User:

Start: 12/31/08 End: 01/31/10 Due: 01/31/11

Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy

Phase: N/A Priority: Normal

NCT ID: NCT01356407 Org: User:

Start: 01/31/11 End: 07/31/11 Due: 07/31/12

Safety and Efficacy of Firmagon® (Degarelix) for Injection

Phase: N/A Priority: Normal

NCT ID: NCT02886598 Org: User:

Start: 09/30/16 End: 03/26/19 Due: 03/26/20

REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)

Phase: N/A Priority: Normal

NCT ID: NCT06545877 Org: User:

Start: 09/16/22 End: 06/22/29 Due: 06/22/30

A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee

Phase: N/A Priority: Normal

NCT ID: NCT00379236 Org: User:

Start: 10/31/06 End: 05/31/08 Due: 05/31/09

Effectiveness and Safety of Firmagon®

Phase: N/A Priority: Normal

NCT ID: NCT00930319 Org: User:

Start: 06/30/09 End: 12/31/13 Due: 12/31/14

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

Phase: N/A Priority: Normal

NCT ID: NCT02018159 Org: User:

Start: 01/31/14 End: 05/12/16 Due: 05/12/17

Mesalazine (PENTASA®) in Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT01517607 Org: User:

Start: 02/29/12 End: 12/31/13 Due: 12/31/14

A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

Phase: N/A Priority: Normal

NCT ID: NCT01292109 Org: User:

Start: 12/31/10 End: 02/29/12 Due: 02/28/13

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Phase: N/A Priority: Normal

NCT ID: NCT01283022 Org: User:

Start: 05/31/11 End: 07/31/11 Due: 07/31/12

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00819247 Org: User:

Start: 03/31/01 End: 08/31/02 Due: 08/31/03

Drug Use-Results Survey on Picoprep® Combination Powder

Phase: N/A Priority: Normal

NCT ID: NCT03631446 Org: User:

Start: 08/29/17 End: 12/31/21 Due: 12/31/22

Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02229253 Org: User:

Start: 09/30/14 End: 10/04/17 Due: 10/04/18

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"

Phase: N/A Priority: Normal

NCT ID: NCT00245505 Org: User:

Start: 02/28/09 End: 07/31/09 Due: 07/31/10

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

Phase: N/A Priority: Normal

NCT ID: NCT00308711 Org: User:

Start: 04/30/06 End: 08/31/07 Due: 08/31/08

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

Phase: N/A Priority: Normal

NCT ID: NCT02368717 Org: User:

Start: 03/31/15 End: 07/25/17 Due: 07/25/18

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

Phase: N/A Priority: Normal

NCT ID: NCT03228680 Org: User:

Start: 07/29/17 End: 07/08/19 Due: 07/08/20

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Phase: N/A Priority: Normal

NCT ID: NCT01729676 Org: User:

Start: 05/31/13 End: 05/31/14 Due: 05/31/15

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

Phase: N/A Priority: Normal

NCT ID: NCT00257556 Org: User:

Start: 10/31/05 End: 04/30/09 Due: 04/30/10

An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02015871 Org: User:

Start: 01/31/14 End: 08/01/17 Due: 08/01/18

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

Phase: N/A Priority: Normal

NCT ID: NCT01552343 Org: User:

Start: 03/31/12 End: 06/30/12 Due: 06/30/13

Post Marketing Surveillance of MENOPUR

Phase: N/A Priority: Normal

NCT ID: NCT01202123 Org: User:

Start: 12/31/08 End: 02/28/14 Due: 02/28/15

Study of Minirin Melt® in Adult Patients With Nocturia

Phase: N/A Priority: Normal

NCT ID: NCT03089073 Org: User:

Start: 07/13/15 End: 10/05/18 Due: 10/05/19

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients	NCT00818623	Ferring Pharmaceuticals	user2@example.com	None	2002-11-30	2004-10-31	2005-10-31	-	-	2025-07-14
To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice	NCT07029451	Ferring Pharmaceuticals	user2@example.com	None	2025-07-31	2028-09-30	2029-09-30	-	-	2025-07-14
MENOPUR® Versus FOLLISTIM®	NCT00802360	Ferring Pharmaceuticals	user2@example.com	None	2008-12-31	2010-01-31	2011-01-31	-	-	2025-07-14
Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy	NCT01356407	Ferring Pharmaceuticals	user2@example.com	None	2011-01-31	2011-07-31	2012-07-31	-	-	2025-07-14
Safety and Efficacy of Firmagon® (Degarelix) for Injection	NCT02886598	Ferring Pharmaceuticals	user2@example.com	None	2016-09-30	2019-03-26	2020-03-26	-	-	2025-07-14
REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)	NCT06545877	Ferring Pharmaceuticals	user2@example.com	None	2022-09-16	2029-06-22	2030-06-22	-	-	2025-07-14
A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee	NCT00379236	Ferring Pharmaceuticals	user2@example.com	None	2006-10-31	2008-05-31	2009-05-31	-	-	2025-07-14
Effectiveness and Safety of Firmagon®	NCT00930319	Ferring Pharmaceuticals	user2@example.com	None	2009-06-30	2013-12-31	2014-12-31	-	-	2025-07-14
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos	NCT02018159	Ferring Pharmaceuticals	user2@example.com	None	2014-01-31	2016-05-12	2017-05-12	-	-	2025-07-14
Mesalazine (PENTASA®) in Ulcerative Colitis	NCT01517607	Ferring Pharmaceuticals	user2@example.com	None	2012-02-29	2013-12-31	2014-12-31	-	-	2025-07-14
A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.	NCT01292109	Ferring Pharmaceuticals	user2@example.com	None	2010-12-31	2012-02-29	2013-02-28	-	-	2025-07-14
Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)	NCT01283022	Ferring Pharmaceuticals	user2@example.com	None	2011-05-31	2011-07-31	2012-07-31	-	-	2025-07-14
The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer	NCT00819247	Ferring Pharmaceuticals	user2@example.com	None	2001-03-31	2002-08-31	2003-08-31	-	-	2025-07-14
Drug Use-Results Survey on Picoprep® Combination Powder	NCT03631446	Ferring Pharmaceuticals	user2@example.com	None	2017-08-29	2021-12-31	2022-12-31	-	-	2025-07-14
Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer	NCT02229253	Ferring Pharmaceuticals	user2@example.com	None	2014-09-30	2017-10-04	2018-10-04	-	-	2025-07-14
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"	NCT00245505	Ferring Pharmaceuticals	user2@example.com	None	2009-02-28	2009-07-31	2010-07-31	-	-	2025-07-14
Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor	NCT00308711	Ferring Pharmaceuticals	user2@example.com	None	2006-04-30	2007-08-31	2008-08-31	-	-	2025-07-14
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase	NCT02368717	Ferring Pharmaceuticals	user2@example.com	None	2015-03-31	2017-07-25	2018-07-25	-	-	2025-07-14
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women	NCT03228680	Ferring Pharmaceuticals	user2@example.com	None	2017-07-29	2019-07-08	2020-07-08	-	-	2025-07-14
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation	NCT01729676	Ferring Pharmaceuticals	user2@example.com	None	2013-05-31	2014-05-31	2015-05-31	-	-	2025-07-14
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa	NCT00257556	Ferring Pharmaceuticals	user2@example.com	None	2005-10-31	2009-04-30	2010-04-30	-	-	2025-07-14
An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer	NCT02015871	Ferring Pharmaceuticals	user2@example.com	None	2014-01-31	2017-08-01	2018-08-01	-	-	2025-07-14
Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary	NCT01552343	Ferring Pharmaceuticals	user2@example.com	None	2012-03-31	2012-06-30	2013-06-30	-	-	2025-07-14
Post Marketing Surveillance of MENOPUR	NCT01202123	Ferring Pharmaceuticals	user2@example.com	None	2008-12-31	2014-02-28	2015-02-28	-	-	2025-07-14
Study of Minirin Melt® in Adult Patients With Nocturia	NCT03089073	Ferring Pharmaceuticals	user2@example.com	None	2015-07-13	2018-10-05	2019-10-05	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance